OmniAb SPAC Presentation Deck

ILLUSTRATIVE REVENUE PROFILES FOR SUCCESSFUL PARTNERED PROGRAMS OMNIAB PARTICIPATION IS WEIGHTED TOWARDS DOWNSTREAM SUCCESS Flexible transaction structures enable optionality for partners while maintaining value for OmniAb Program A Program B Research / Upfront Clinical Milestones Commercial Milestones / Royalties Target equivalent NPV for all structures 31 1 Per product gross revenue potential, if approved and marketed, of up to $1 billion+ to OmniAb OmniAb

View entire presentation